Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 9, 2008
Can the Spanish care system assume the new costs of medications against cancer?Carlos Camps, Cristina Caballero, Rafael Sirera, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2008
Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancerVega Iranzo, Roy M Bremnes, Piedad Almendros, et al.
Animal Reproduction Science|May 16, 2025
Diagnostic value of endoscopically guided transcervical catheterization for cytological and bacteriological sampling in canine endometritis and normal uterusSol Arioni, Analía Arizmendi, María Czernigow, et al.
Clinical Lung Cancer|July 7, 2011
Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patientsEloisa Jantus-Lewintre, Rafael Sirera, Andrea Cabrera, et al.
Lung Cancer (Amsterdam, Netherlands)|April 13, 2011
Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLCEloisa Jantus-Lewintre, Elena Sanmartín, Rafael Sirera, et al.
Intensive & Critical Care Nursing|December 17, 2022
Nurses' clinical leadership in the intensive care unit: A scoping reviewAndrea Iraizoz-Iraizoz, Raquel García-García, Andrea Navarrete-Muro, et al.
Revista Espanola De Cardiologia|May 11, 2010
Intravascular ultrasound measurement of the aortic lumenAna Blasco, Ana Piazza, Javier Goicolea, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 19, 2005
[Analysis of tumour-derived DNA in serum in advanced non-microcytic lung cancer: might it be a prognostic factor?]Carlos Camps Herrero, Pilar Bayo Zaera, Rafael Sirera Pérez, et al.
Lung Cancer (Amsterdam, Netherlands)|February 5, 2008
Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancerRafael Sirera, Mireia Gil, Ana Blasco, et al.
Anticancer Research|December 13, 2005
Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerabilityCarlos Camps, Cristina Caballero, Ana Blasco, et al.
Pageof 10